LAURUS LABS
Back to Income Statement
|
LAURUS LABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹5,554 Cr | ₹5,041 Cr | ₹6,041 Cr | ₹4,936 Cr | ₹4,814 Cr |
What is the latest Revenue of LAURUS LABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹5,554 Cr |
| Mar2024 | ₹5,041 Cr |
| Mar2023 | ₹6,041 Cr |
| Mar2022 | ₹4,936 Cr |
| Mar2021 | ₹4,814 Cr |
How is Revenue of LAURUS LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,554 Cr | 10.18 | |
| Mar2024 | ₹5,041 Cr | -16.55 | |
| Mar2023 | ₹6,041 Cr | 22.39 | |
| Mar2022 | ₹4,936 Cr | 2.54 | |
| Mar2021 | ₹4,814 Cr | - | |
Compare Revenue of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹58,433.4 Cr | -1.9% | 6.3% | 79.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -1.9% |
6.3% |
79.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses